Drug Profile
EDP 1066
Alternative Names: EDP1066Latest Information Update: 25 Nov 2021
Price :
$50
*
At a glance
- Originator Evelo Biosciences
- Developer Evelo Biosciences; University of Surrey
- Class Anti-inflammatories; Antipsoriatics; Bacteria; Immunotherapies; Skin disorder therapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Atopic dermatitis; Crohn's disease; Psoriasis; Ulcerative colitis